BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 1991829)

  • 1. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.
    Bucala R; Tracey KJ; Cerami A
    J Clin Invest; 1991 Feb; 87(2):432-8. PubMed ID: 1991829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and vascular tissue arginine are decreased in diabetes: acute arginine supplementation restores endothelium-dependent relaxation by augmenting cGMP production.
    Pieper GM; Dondlinger LA
    J Pharmacol Exp Ther; 1997 Nov; 283(2):684-91. PubMed ID: 9353386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products quench nitric oxide in vitro.
    Uhlmann S; Rezzoug K; Friedrichs U; Hoffmann S; Wiedemann P
    Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):860-6. PubMed ID: 12397436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysiology and clinical implications.
    Rongen GA; Smits P; Thien T
    Neth J Med; 1994 Jan; 44(1):26-35. PubMed ID: 8202203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
    Wang S; Peng Q; Zhang J; Liu L
    Cardiovasc Res; 2008 Nov; 80(2):255-62. PubMed ID: 18591204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in venous endothelial cell and smooth muscle cell relaxation induced by high glucose concentrations can be prevented by aminoguanidine.
    Davies MG; Hagen PO
    J Surg Res; 1996 Jul; 63(2):474-9. PubMed ID: 8661245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide and vascular responses in Type I diabetes.
    Chan NN; Vallance P; Colhoun HM
    Diabetologia; 2000 Feb; 43(2):137-47. PubMed ID: 10753034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in vasodilator responses of vascular smooth muscles and nitric oxide system in experimental diabetes mellitus].
    Sahach VF; Tkachenko MM; Prysiazhna OD; Kotsiuruba AV; Mehed' OF
    Fiziol Zh (1994); 2003; 49(4):24-32. PubMed ID: 14509924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a nitronyl nitroxide to discriminate the contribution of nitric oxide radical in endothelium-dependent relaxation of control and diabetic blood vessels.
    Pieper GM; Siebeneich W
    J Pharmacol Exp Ther; 1997 Oct; 283(1):138-47. PubMed ID: 9336318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired NO-dependent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus is restored by acute administration of folate.
    van Etten RW; de Koning EJ; Verhaar MC; Gaillard CA; Rabelink TJ
    Diabetologia; 2002 Jul; 45(7):1004-10. PubMed ID: 12136399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoguanidine and the prevention of leukocyte dysfunction in diabetes mellitus: a direct vital microscopic study.
    Sannomiya P; Oliveira MA; Fortes ZB
    Br J Pharmacol; 1997 Nov; 122(5):894-8. PubMed ID: 9384505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K; Sármán B; Jermendy G; Somogyi A
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of vascular responses in endothelial nitric oxide synthase/cyclooxygenase-1 double-knockout mice: key role for endothelium-derived hyperpolarizing factor in the regulation of blood pressure in vivo.
    Scotland RS; Madhani M; Chauhan S; Moncada S; Andresen J; Nilsson H; Hobbs AJ; Ahluwalia A
    Circulation; 2005 Feb; 111(6):796-803. PubMed ID: 15699263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of some products of protein catabolism on the endothelium-dependent and -independent relaxation of rabbit thoracic aorta rings.
    Sorrentino R; Sorrentino L; Pinto A
    J Pharmacol Exp Ther; 1993 Aug; 266(2):626-33. PubMed ID: 8355196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial beta3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization.
    Dessy C; Moniotte S; Ghisdal P; Havaux X; Noirhomme P; Balligand JL
    Circulation; 2004 Aug; 110(8):948-54. PubMed ID: 15302798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 protects against endothelial dysfunction induced by high glucose levels in rats.
    Qian LB; Wang HP; Qiu WL; Huang H; Bruce IC; Xia Q
    Vascul Pharmacol; 2006 Dec; 45(6):374-82. PubMed ID: 16837248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischaemia enhances the role of Ca2+-activated K+ channels in endothelium-dependent and nitric oxide-mediated dilatation of the rat hindquarters vasculature.
    Woodman OL; Wongsawatkul O
    Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):254-60. PubMed ID: 15053823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of aminoguanidine on oxidative modification of proteins in experimental diabetes mellitus in rats].
    Brodiak IV; Sybirna NO
    Ukr Biokhim Zh (1999); 2006; 78(5):114-9. PubMed ID: 17290789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide: from basic research on isolated blood vessels to clinical relevance in diabetes.
    Furchgott RF
    An R Acad Nac Med (Madr); 1998; 115(2):317-31. PubMed ID: 9882827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.